Chong Kun Dang names new CEO

Published: 2012-09-04 06:57:00

Updated: 2012-09-04 06:57:00

Chong Kun Dang Pharmaceutical Co. announced last Friday that incumbent Vice Chairman Kim Jung-woo will lead the Seoul-based drug manufacturer based on his 40-year background in the company.

A graduate of College of Medicine, Seoul National University, Kim earned a doctorate degree at ChungAng ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK